Wenxin Qin
机构：Shanghai Jiao Tong University, Renji Hospital, Shanghai Cancer Institute · ORCID：0000-0002-1989-3027
发表论文 261 篇 · 总被引 12434 次 · h-index 55
代表论文
- Hepatocellular carcinoma: signaling pathways and therapeutic advances (2025 · Signal Transduction and Targeted Therapy · 被引 301)
- PRMT1-mediated modification of H4R3me2a promotes liver cancer progression by enhancing the transcriptional activity of SOX18 (2025 · Hepatology Communications · 被引 4)
- CRISPR screens identify the ATPase VCP as a druggable therapeutic vulnerability in cholangiocarcinoma (2025 · Proceedings of the National Academy of Sciences · 被引 1)
- XPO1 inhibition induces NCOR1-Dependent oxidative stress to suppress hepatocellular carcinoma (2026 · Cell chemical biology)
- Table S2 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy (2026)
- Figure S8 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy (2026)